| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-ret | 32 | 2021 | 370 | 4.390 |
Why?
|
| Thyroid Neoplasms | 59 | 2022 | 1867 | 4.270 |
Why?
|
| Carcinoma, Medullary | 23 | 2017 | 248 | 3.090 |
Why?
|
| Carcinoma, Neuroendocrine | 16 | 2020 | 716 | 2.110 |
Why?
|
| Alternative Splicing | 13 | 2012 | 582 | 1.690 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 8 | 2012 | 36 | 1.690 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 19 | 2018 | 115 | 1.660 |
Why?
|
| Calcitonin | 23 | 2016 | 186 | 1.640 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 19 | 2004 | 661 | 1.590 |
Why?
|
| Receptors, Fibroblast Growth Factor | 8 | 2004 | 153 | 1.490 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 4 | 2012 | 55 | 1.190 |
Why?
|
| Exons | 21 | 2017 | 1328 | 1.150 |
Why?
|
| Germ-Line Mutation | 17 | 2019 | 1047 | 1.140 |
Why?
|
| Cell Transformation, Neoplastic | 10 | 2016 | 2359 | 1.110 |
Why?
|
| Oncogenes | 4 | 2020 | 672 | 1.070 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 12 | 2017 | 141 | 1.050 |
Why?
|
| RNA Splicing | 10 | 2016 | 369 | 0.960 |
Why?
|
| Pheochromocytoma | 12 | 2018 | 281 | 0.890 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 3 | 2019 | 53 | 0.880 |
Why?
|
| Calcitonin Gene-Related Peptide | 15 | 2013 | 163 | 0.860 |
Why?
|
| Thyroid Gland | 7 | 2018 | 353 | 0.820 |
Why?
|
| Phosphoproteins | 5 | 2016 | 1149 | 0.750 |
Why?
|
| Sodium-Hydrogen Exchangers | 3 | 2016 | 134 | 0.740 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 5 | 2022 | 260 | 0.730 |
Why?
|
| Point Mutation | 13 | 2012 | 768 | 0.710 |
Why?
|
| Introns | 8 | 2018 | 431 | 0.700 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2018 | 8868 | 0.690 |
Why?
|
| Glioblastoma | 12 | 2012 | 1798 | 0.690 |
Why?
|
| Paraganglioma | 5 | 2018 | 170 | 0.680 |
Why?
|
| Proto-Oncogene Proteins | 16 | 2016 | 2484 | 0.580 |
Why?
|
| Adrenal Gland Neoplasms | 9 | 2018 | 489 | 0.570 |
Why?
|
| Calixarenes | 1 | 2015 | 1 | 0.540 |
Why?
|
| Chromatography | 1 | 2015 | 49 | 0.530 |
Why?
|
| Uranium | 1 | 2015 | 7 | 0.530 |
Why?
|
| Chemical Fractionation | 1 | 2015 | 27 | 0.530 |
Why?
|
| Guanylate Cyclase | 2 | 2012 | 74 | 0.520 |
Why?
|
| Minerals | 1 | 2015 | 71 | 0.520 |
Why?
|
| Urinalysis | 1 | 2015 | 84 | 0.510 |
Why?
|
| Phenols | 1 | 2015 | 107 | 0.500 |
Why?
|
| Thyroidectomy | 10 | 2020 | 486 | 0.490 |
Why?
|
| Myosin Heavy Chains | 1 | 2014 | 129 | 0.490 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2021 | 755 | 0.480 |
Why?
|
| DNA, Neoplasm | 5 | 2017 | 1905 | 0.480 |
Why?
|
| Mutation | 30 | 2022 | 15173 | 0.470 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 429 | 0.460 |
Why?
|
| Intestinal Mucosa | 2 | 2016 | 1080 | 0.440 |
Why?
|
| Multiple Endocrine Neoplasia | 4 | 2020 | 57 | 0.440 |
Why?
|
| Hyperparathyroidism | 3 | 2016 | 93 | 0.430 |
Why?
|
| Base Sequence | 25 | 2011 | 4887 | 0.420 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 5 | 1999 | 42 | 0.420 |
Why?
|
| Cell Line, Tumor | 17 | 2020 | 14541 | 0.410 |
Why?
|
| Proto-Oncogenes | 6 | 2007 | 201 | 0.400 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 216 | 0.400 |
Why?
|
| Humans | 132 | 2022 | 261371 | 0.400 |
Why?
|
| Receptors, Drug | 5 | 1999 | 48 | 0.390 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2012 | 587 | 0.380 |
Why?
|
| Molecular Sequence Data | 22 | 2011 | 6061 | 0.380 |
Why?
|
| Multiple Endocrine Neoplasia Type 2b | 6 | 2018 | 53 | 0.370 |
Why?
|
| ATP-Binding Cassette Transporters | 5 | 1999 | 299 | 0.370 |
Why?
|
| Endopeptidases | 1 | 2011 | 220 | 0.370 |
Why?
|
| Potassium Channels | 5 | 1999 | 162 | 0.360 |
Why?
|
| Neoplasm Proteins | 8 | 2017 | 3228 | 0.350 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1516 | 0.350 |
Why?
|
| Glioma | 4 | 2014 | 1963 | 0.340 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2019 | 5533 | 0.340 |
Why?
|
| Glycoproteins | 2 | 2009 | 746 | 0.340 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 8 | 2008 | 182 | 0.330 |
Why?
|
| Enhancer Elements, Genetic | 5 | 2018 | 463 | 0.330 |
Why?
|
| RNA Precursors | 5 | 2008 | 137 | 0.320 |
Why?
|
| DNA Mutational Analysis | 12 | 2017 | 2280 | 0.320 |
Why?
|
| RNA, Messenger | 17 | 2011 | 6117 | 0.320 |
Why?
|
| RNA Interference | 5 | 2016 | 1405 | 0.320 |
Why?
|
| Proto-Oncogene Proteins B-raf | 7 | 2022 | 1283 | 0.300 |
Why?
|
| Tumor Cells, Cultured | 16 | 2009 | 5382 | 0.300 |
Why?
|
| RNA Processing, Post-Transcriptional | 5 | 1998 | 154 | 0.300 |
Why?
|
| Drosophila Proteins | 9 | 2001 | 858 | 0.290 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2021 | 4756 | 0.290 |
Why?
|
| Activating Transcription Factor 4 | 2 | 2018 | 73 | 0.290 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2021 | 224 | 0.280 |
Why?
|
| Neuropeptides | 4 | 1987 | 154 | 0.280 |
Why?
|
| Pedigree | 14 | 2018 | 1889 | 0.280 |
Why?
|
| Nuclear Proteins | 6 | 2018 | 3315 | 0.280 |
Why?
|
| Polymerase Chain Reaction | 10 | 2017 | 3185 | 0.280 |
Why?
|
| Genetic Testing | 9 | 2018 | 1587 | 0.280 |
Why?
|
| Biomarkers, Tumor | 6 | 2021 | 10332 | 0.260 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2004 | 10 | 0.250 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2004 | 18 | 0.250 |
Why?
|
| Adult | 41 | 2021 | 77942 | 0.250 |
Why?
|
| Hyperinsulinism | 5 | 1999 | 84 | 0.250 |
Why?
|
| Receptor, Notch1 | 1 | 2006 | 218 | 0.250 |
Why?
|
| Brain Neoplasms | 6 | 2012 | 4848 | 0.250 |
Why?
|
| Antigens, CD | 1 | 2009 | 1378 | 0.250 |
Why?
|
| Cell Proliferation | 5 | 2018 | 7219 | 0.250 |
Why?
|
| Peptides | 2 | 2009 | 1475 | 0.240 |
Why?
|
| Transcription, Genetic | 12 | 2018 | 3127 | 0.240 |
Why?
|
| Carcinoma | 7 | 2016 | 2576 | 0.240 |
Why?
|
| Succinate Dehydrogenase | 2 | 2006 | 43 | 0.230 |
Why?
|
| Transfection | 10 | 2014 | 2926 | 0.230 |
Why?
|
| RNA-Binding Proteins | 3 | 2004 | 979 | 0.230 |
Why?
|
| Hypoglycemia | 5 | 1999 | 212 | 0.230 |
Why?
|
| Middle Aged | 36 | 2021 | 86207 | 0.230 |
Why?
|
| Gene Expression Regulation | 10 | 2015 | 4015 | 0.230 |
Why?
|
| Female | 55 | 2021 | 141867 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 2 | 2009 | 1491 | 0.220 |
Why?
|
| Neoplasms | 3 | 2021 | 15190 | 0.220 |
Why?
|
| Male | 50 | 2021 | 122928 | 0.210 |
Why?
|
| Genetic Association Studies | 2 | 2016 | 1084 | 0.210 |
Why?
|
| Phenotype | 15 | 2019 | 6267 | 0.210 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 1990 | 218 | 0.200 |
Why?
|
| Ribonucleoproteins | 2 | 2000 | 123 | 0.200 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2014 | 214 | 0.200 |
Why?
|
| Liver Neoplasms, Experimental | 7 | 1987 | 186 | 0.200 |
Why?
|
| Aged | 27 | 2021 | 70109 | 0.190 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2019 | 306 | 0.190 |
Why?
|
| Parathyroid Neoplasms | 2 | 2016 | 185 | 0.190 |
Why?
|
| Survival Analysis | 6 | 2021 | 9179 | 0.190 |
Why?
|
| DNA-Binding Proteins | 7 | 2018 | 4790 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 1076 | 0.180 |
Why?
|
| Cohort Studies | 5 | 2021 | 9237 | 0.180 |
Why?
|
| Calcitriol | 3 | 1989 | 124 | 0.180 |
Why?
|
| alpha-Fetoproteins | 7 | 1987 | 232 | 0.170 |
Why?
|
| Young Adult | 14 | 2020 | 21435 | 0.170 |
Why?
|
| Genotyping Techniques | 1 | 2019 | 166 | 0.170 |
Why?
|
| Dinucleotide Repeats | 1 | 1998 | 10 | 0.170 |
Why?
|
| Parathyroidectomy | 2 | 2013 | 203 | 0.170 |
Why?
|
| Chernobyl Nuclear Accident | 1 | 2018 | 12 | 0.170 |
Why?
|
| Animals | 38 | 2021 | 59390 | 0.170 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2018 | 35 | 0.170 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2014 | 986 | 0.160 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 642 | 0.160 |
Why?
|
| Somatostatin | 3 | 1989 | 114 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 2 | 2016 | 846 | 0.160 |
Why?
|
| Sulfonylurea Compounds | 3 | 1996 | 32 | 0.160 |
Why?
|
| Phosphorylation | 6 | 2016 | 4798 | 0.160 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 127 | 0.160 |
Why?
|
| Oxidoreductases | 1 | 1998 | 172 | 0.150 |
Why?
|
| DNA | 8 | 1999 | 2678 | 0.150 |
Why?
|
| Radiation Exposure | 1 | 2018 | 73 | 0.150 |
Why?
|
| Endocrine System Diseases | 2 | 2017 | 83 | 0.150 |
Why?
|
| Multienzyme Complexes | 1 | 1998 | 215 | 0.150 |
Why?
|
| Iodine Radioisotopes | 1 | 2019 | 371 | 0.150 |
Why?
|
| Prognosis | 11 | 2021 | 21712 | 0.150 |
Why?
|
| Membrane Proteins | 3 | 2015 | 2813 | 0.150 |
Why?
|
| Cell Movement | 4 | 2018 | 2455 | 0.140 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 271 | 0.140 |
Why?
|
| Genes, APC | 1 | 2016 | 70 | 0.140 |
Why?
|
| Fructokinases | 1 | 2016 | 8 | 0.140 |
Why?
|
| NF-kappa B | 2 | 2014 | 1545 | 0.140 |
Why?
|
| Retinoblastoma Protein | 1 | 2017 | 332 | 0.140 |
Why?
|
| Antineoplastic Agents | 6 | 2020 | 14292 | 0.140 |
Why?
|
| Dexamethasone | 6 | 1987 | 1448 | 0.140 |
Why?
|
| Soluble Guanylyl Cyclase | 2 | 2012 | 15 | 0.130 |
Why?
|
| Resins, Synthetic | 1 | 2015 | 3 | 0.130 |
Why?
|
| Chemical Precipitation | 1 | 2015 | 22 | 0.130 |
Why?
|
| I-kappa B Kinase | 2 | 2014 | 250 | 0.130 |
Why?
|
| Cytogenetic Analysis | 1 | 2017 | 568 | 0.130 |
Why?
|
| Calcium Chloride | 1 | 2015 | 23 | 0.130 |
Why?
|
| Child | 19 | 2020 | 29109 | 0.130 |
Why?
|
| Protein Isoforms | 2 | 2011 | 836 | 0.130 |
Why?
|
| Aged, 80 and over | 13 | 2021 | 29897 | 0.130 |
Why?
|
| Physician's Role | 1 | 2018 | 237 | 0.130 |
Why?
|
| Polymorphism, Genetic | 2 | 1998 | 1448 | 0.130 |
Why?
|
| Radiation Tolerance | 1 | 2019 | 629 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2015 | 34 | 0.130 |
Why?
|
| Cancer Care Facilities | 2 | 2017 | 884 | 0.130 |
Why?
|
| DNA Primers | 6 | 2008 | 1391 | 0.130 |
Why?
|
| Adolescent | 18 | 2020 | 31233 | 0.130 |
Why?
|
| beta Catenin | 2 | 2016 | 687 | 0.130 |
Why?
|
| Signal Transduction | 9 | 2018 | 11955 | 0.130 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2015 | 142 | 0.130 |
Why?
|
| Sepharose | 1 | 1994 | 32 | 0.130 |
Why?
|
| Genotype | 9 | 2018 | 4100 | 0.120 |
Why?
|
| Adenoma | 2 | 2016 | 716 | 0.120 |
Why?
|
| Carcinoma, Papillary, Follicular | 1 | 2014 | 28 | 0.120 |
Why?
|
| Wnt Proteins | 1 | 2016 | 397 | 0.120 |
Why?
|
| Proteolysis | 2 | 2015 | 370 | 0.120 |
Why?
|
| Cyclin D1 | 1 | 2016 | 576 | 0.120 |
Why?
|
| Carcinoid Tumor | 1 | 2016 | 280 | 0.120 |
Why?
|
| Gene Deletion | 3 | 2017 | 1438 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 5 | 2017 | 5068 | 0.110 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 1362 | 0.110 |
Why?
|
| Radiopharmaceuticals | 1 | 2019 | 1311 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 2 | 2008 | 256 | 0.110 |
Why?
|
| Mice | 17 | 2016 | 34373 | 0.110 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2015 | 223 | 0.110 |
Why?
|
| Survivors | 1 | 2018 | 1033 | 0.110 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2012 | 33 | 0.110 |
Why?
|
| Morphogenesis | 1 | 2014 | 336 | 0.110 |
Why?
|
| Apoptosis | 2 | 2018 | 7589 | 0.110 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 442 | 0.110 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 14874 | 0.110 |
Why?
|
| Sulfonylurea Receptors | 5 | 1999 | 22 | 0.110 |
Why?
|
| Tumor Burden | 2 | 2016 | 1988 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2018 | 1125 | 0.110 |
Why?
|
| Trans-Splicing | 2 | 2002 | 6 | 0.110 |
Why?
|
| Carcinoma, Papillary | 1 | 2016 | 583 | 0.110 |
Why?
|
| Niacinamide | 1 | 2014 | 421 | 0.100 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2013 | 135 | 0.100 |
Why?
|
| Calcium | 3 | 1999 | 1541 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 419 | 0.100 |
Why?
|
| Thyroid Hormones | 1 | 2012 | 110 | 0.100 |
Why?
|
| Gastrinoma | 1 | 2011 | 25 | 0.100 |
Why?
|
| RNA, Neoplasm | 3 | 2008 | 771 | 0.100 |
Why?
|
| Risk Assessment | 4 | 2019 | 6867 | 0.100 |
Why?
|
| Cell Lineage | 1 | 2015 | 661 | 0.100 |
Why?
|
| Liver | 4 | 2003 | 2900 | 0.100 |
Why?
|
| Protein Precursors | 1 | 2013 | 240 | 0.100 |
Why?
|
| HeLa Cells | 8 | 2008 | 1638 | 0.100 |
Why?
|
| Gastrins | 1 | 2011 | 55 | 0.100 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2016 | 607 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 1999 | 1662 | 0.100 |
Why?
|
| Neoplasm Staging | 4 | 2017 | 13667 | 0.100 |
Why?
|
| Retrospective Studies | 15 | 2020 | 37934 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2016 | 5675 | 0.100 |
Why?
|
| Neuroendocrine Tumors | 1 | 2017 | 634 | 0.100 |
Why?
|
| Communication | 1 | 2018 | 876 | 0.100 |
Why?
|
| Thymus Neoplasms | 1 | 2016 | 401 | 0.100 |
Why?
|
| Tissue Array Analysis | 2 | 2018 | 759 | 0.100 |
Why?
|
| Disease-Free Survival | 3 | 2020 | 10001 | 0.100 |
Why?
|
| Duodenal Neoplasms | 1 | 2011 | 138 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 2477 | 0.100 |
Why?
|
| Gene Expression Profiling | 6 | 2015 | 5150 | 0.100 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2010 | 67 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 3 | 2018 | 2330 | 0.090 |
Why?
|
| Phenylurea Compounds | 1 | 2014 | 580 | 0.090 |
Why?
|
| Indoles | 1 | 2016 | 1009 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2014 | 853 | 0.090 |
Why?
|
| Brain | 1 | 2004 | 4099 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2018 | 5177 | 0.090 |
Why?
|
| Colon | 1 | 2014 | 670 | 0.090 |
Why?
|
| Cyclic AMP | 2 | 1989 | 358 | 0.090 |
Why?
|
| AC133 Antigen | 1 | 2009 | 110 | 0.090 |
Why?
|
| Nogo Proteins | 1 | 2009 | 11 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 1437 | 0.090 |
Why?
|
| Colorectal Neoplasms | 2 | 2016 | 3578 | 0.090 |
Why?
|
| Neoadjuvant Therapy | 2 | 2020 | 4977 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1339 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 3978 | 0.090 |
Why?
|
| Lymphatic Metastasis | 2 | 2017 | 4843 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2015 | 2083 | 0.090 |
Why?
|
| Bone and Bones | 2 | 2003 | 619 | 0.090 |
Why?
|
| Transcription Factors | 3 | 2018 | 5249 | 0.080 |
Why?
|
| Kidney Medulla | 1 | 1989 | 43 | 0.080 |
Why?
|
| Actin Cytoskeleton | 1 | 2009 | 82 | 0.080 |
Why?
|
| Myelin Proteins | 1 | 2009 | 90 | 0.080 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2008 | 30 | 0.080 |
Why?
|
| Lymph Node Excision | 2 | 2011 | 1960 | 0.080 |
Why?
|
| Osteomalacia | 1 | 2008 | 36 | 0.080 |
Why?
|
| Texas | 2 | 2017 | 6307 | 0.080 |
Why?
|
| Spheroids, Cellular | 1 | 2009 | 222 | 0.080 |
Why?
|
| Genetic Counseling | 2 | 2018 | 380 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2004 | 2075 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 4890 | 0.080 |
Why?
|
| Cell Count | 1 | 2009 | 506 | 0.080 |
Why?
|
| Hemangiopericytoma | 1 | 2008 | 56 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 1876 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 2288 | 0.080 |
Why?
|
| Cell Line | 8 | 2014 | 5079 | 0.080 |
Why?
|
| Clinical Trials as Topic | 2 | 2015 | 3721 | 0.080 |
Why?
|
| ErbB Receptors | 2 | 2016 | 2293 | 0.080 |
Why?
|
| Hypercalcemia | 1 | 1989 | 137 | 0.080 |
Why?
|
| Rats | 12 | 1999 | 6084 | 0.080 |
Why?
|
| Phorbol Esters | 1 | 1987 | 39 | 0.080 |
Why?
|
| Glaucoma, Open-Angle | 1 | 1988 | 38 | 0.080 |
Why?
|
| raf Kinases | 1 | 2007 | 81 | 0.080 |
Why?
|
| Sepsis | 1 | 2013 | 653 | 0.080 |
Why?
|
| Spliceosomes | 2 | 2013 | 75 | 0.080 |
Why?
|
| Dacarbazine | 1 | 2009 | 485 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 2046 | 0.080 |
Why?
|
| Nucleic Acid Hybridization | 6 | 1989 | 538 | 0.070 |
Why?
|
| Pancreatectomy | 1 | 2011 | 652 | 0.070 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 292 | 0.070 |
Why?
|
| Age of Onset | 2 | 2013 | 826 | 0.070 |
Why?
|
| Binding Sites | 1 | 2011 | 2166 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 314 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2016 | 1823 | 0.070 |
Why?
|
| Plasmids | 5 | 2001 | 834 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 4550 | 0.070 |
Why?
|
| DNA, Complementary | 3 | 2017 | 869 | 0.070 |
Why?
|
| Medical Oncology | 1 | 2015 | 1425 | 0.070 |
Why?
|
| Syndrome | 2 | 2006 | 1351 | 0.070 |
Why?
|
| Transcription Factor HES-1 | 1 | 2006 | 49 | 0.070 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2006 | 22 | 0.070 |
Why?
|
| Sequence Deletion | 3 | 1999 | 874 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2009 | 1001 | 0.070 |
Why?
|
| Face | 1 | 1989 | 273 | 0.070 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 691 | 0.070 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2006 | 151 | 0.070 |
Why?
|
| Recombinant Proteins | 4 | 2017 | 2913 | 0.070 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2007 | 107 | 0.070 |
Why?
|
| Salvage Therapy | 1 | 2014 | 2054 | 0.070 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2006 | 155 | 0.070 |
Why?
|
| Calcinosis | 1 | 1989 | 422 | 0.060 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 2005 | 42 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2006 | 274 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2011 | 1679 | 0.060 |
Why?
|
| Choriocarcinoma | 1 | 2004 | 47 | 0.060 |
Why?
|
| Threonine | 3 | 2015 | 160 | 0.060 |
Why?
|
| Caspase 7 | 1 | 2004 | 34 | 0.060 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2004 | 88 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2004 | 26 | 0.060 |
Why?
|
| Neoplasm Metastasis | 4 | 2017 | 5111 | 0.060 |
Why?
|
| Mutation, Missense | 2 | 2013 | 1153 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2004 | 107 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2012 | 2017 | 0.060 |
Why?
|
| Pancreatic Diseases | 2 | 1995 | 108 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2006 | 1165 | 0.060 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2021 | 521 | 0.060 |
Why?
|
| Infant | 7 | 2014 | 13285 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 2016 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 3632 | 0.060 |
Why?
|
| Preimplantation Diagnosis | 1 | 2003 | 47 | 0.060 |
Why?
|
| Actinoid Series Elements | 1 | 2003 | 1 | 0.060 |
Why?
|
| Aortic Valve Stenosis | 1 | 1989 | 476 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 1826 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2004 | 469 | 0.060 |
Why?
|
| Feasibility Studies | 3 | 2017 | 2290 | 0.060 |
Why?
|
| Heterozygote | 2 | 2017 | 1017 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 1987 | 629 | 0.060 |
Why?
|
| Digestive System | 1 | 2003 | 114 | 0.050 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 4985 | 0.050 |
Why?
|
| Child, Preschool | 7 | 2014 | 16243 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2003 | 246 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2006 | 620 | 0.050 |
Why?
|
| Insulinoma | 1 | 2002 | 55 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2012 | 606 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2017 | 1389 | 0.050 |
Why?
|
| Time Factors | 4 | 2020 | 12920 | 0.050 |
Why?
|
| Ultrasonography | 1 | 1989 | 1860 | 0.050 |
Why?
|
| Adenoviruses, Human | 1 | 2002 | 181 | 0.050 |
Why?
|
| Caspases | 1 | 2004 | 661 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 2018 | 7539 | 0.050 |
Why?
|
| Haplotypes | 3 | 2019 | 856 | 0.050 |
Why?
|
| Islets of Langerhans | 3 | 1999 | 229 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 1996 | 4226 | 0.050 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2003 | 221 | 0.050 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1999 | 239 | 0.050 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 1958 | 0.050 |
Why?
|
| Intellectual Disability | 1 | 1989 | 1032 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1994 | 82 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2001 | 70 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1998 | 349 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2015 | 4304 | 0.050 |
Why?
|
| Cell Nucleus | 4 | 2015 | 1613 | 0.050 |
Why?
|
| Nociceptors | 1 | 2001 | 86 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 1138 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 1 | 2021 | 126 | 0.050 |
Why?
|
| 3T3 Cells | 4 | 2002 | 354 | 0.050 |
Why?
|
| Pituitary Neoplasms | 1 | 2002 | 203 | 0.050 |
Why?
|
| Pyridines | 2 | 2018 | 1243 | 0.040 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2013 | 2979 | 0.040 |
Why?
|
| Arthritis | 1 | 2001 | 139 | 0.040 |
Why?
|
| RNA, Catalytic | 1 | 1999 | 37 | 0.040 |
Why?
|
| Survival Rate | 3 | 2017 | 12222 | 0.040 |
Why?
|
| Bone Density | 1 | 2002 | 474 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 2208 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2014 | 1759 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2019 | 12871 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2002 | 666 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2018 | 639 | 0.040 |
Why?
|
| Thyroglobulin | 1 | 2019 | 62 | 0.040 |
Why?
|
| Carcinogenesis | 2 | 2016 | 1027 | 0.040 |
Why?
|
| Codon | 4 | 2004 | 241 | 0.040 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1999 | 68 | 0.040 |
Why?
|
| Electron Transport Complex II | 1 | 1998 | 5 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 4543 | 0.040 |
Why?
|
| Ligases | 1 | 2019 | 70 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 1996 | 135 | 0.040 |
Why?
|
| Oncogene Addiction | 1 | 2018 | 4 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2014 | 1488 | 0.040 |
Why?
|
| Indolizines | 1 | 2018 | 45 | 0.040 |
Why?
|
| Models, Biological | 2 | 2003 | 3248 | 0.040 |
Why?
|
| Pyridinium Compounds | 1 | 2018 | 63 | 0.040 |
Why?
|
| Cyclic N-Oxides | 1 | 2018 | 106 | 0.040 |
Why?
|
| Hot Temperature | 2 | 2001 | 280 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2019 | 294 | 0.040 |
Why?
|
| Cell Survival | 1 | 2004 | 3042 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2017 | 13 | 0.040 |
Why?
|
| Cisplatin | 2 | 2015 | 2432 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 2015 | 3080 | 0.040 |
Why?
|
| Nerve Growth Factors | 1 | 1998 | 109 | 0.040 |
Why?
|
| DNA, Recombinant | 1 | 2017 | 121 | 0.040 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 1998 | 81 | 0.040 |
Why?
|
| Risk Factors | 4 | 2019 | 17516 | 0.040 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2017 | 129 | 0.040 |
Why?
|
| Radiometry | 1 | 2003 | 980 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 1997 | 286 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group F-H | 1 | 2016 | 5 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 1757 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2021 | 3549 | 0.040 |
Why?
|
| Ribose-Phosphate Pyrophosphokinase | 1 | 2016 | 5 | 0.040 |
Why?
|
| Phosphothreonine | 1 | 2016 | 20 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2016 | 2054 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 1995 | 402 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2012 | 1516 | 0.030 |
Why?
|
| Gene Expression | 3 | 2015 | 3558 | 0.030 |
Why?
|
| Age Factors | 2 | 2017 | 5365 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2016 | 810 | 0.030 |
Why?
|
| Nucleotides | 1 | 1996 | 163 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2008 | 2576 | 0.030 |
Why?
|
| Nucleic Acids | 1 | 2016 | 43 | 0.030 |
Why?
|
| Patient Selection | 2 | 2019 | 2057 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 861 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 495 | 0.030 |
Why?
|
| Mitotane | 1 | 2015 | 39 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2017 | 602 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 2016 | 127 | 0.030 |
Why?
|
| Kinetics | 3 | 1987 | 2036 | 0.030 |
Why?
|
| Biomarkers | 2 | 2018 | 5034 | 0.030 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2016 | 160 | 0.030 |
Why?
|
| Algorithms | 1 | 2007 | 3887 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 260 | 0.030 |
Why?
|
| Genes, Dominant | 2 | 2004 | 331 | 0.030 |
Why?
|
| Research Subjects | 1 | 2015 | 64 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2016 | 147 | 0.030 |
Why?
|
| Gain of Function Mutation | 1 | 2016 | 126 | 0.030 |
Why?
|
| Genes | 2 | 1987 | 480 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 1310 | 0.030 |
Why?
|
| Kidney | 1 | 1984 | 2153 | 0.030 |
Why?
|
| Chromatin | 2 | 2013 | 942 | 0.030 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1994 | 34 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 280 | 0.030 |
Why?
|
| Templates, Genetic | 1 | 1994 | 86 | 0.030 |
Why?
|
| Methionine | 2 | 2010 | 159 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 995 | 0.030 |
Why?
|
| Motivation | 1 | 2018 | 499 | 0.030 |
Why?
|
| Tongue Neoplasms | 1 | 1996 | 246 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 1997 | 905 | 0.030 |
Why?
|
| PDZ Domains | 1 | 2014 | 20 | 0.030 |
Why?
|
| Analgesics | 1 | 1997 | 391 | 0.030 |
Why?
|
| Fish Oils | 1 | 1994 | 88 | 0.030 |
Why?
|
| Counseling | 1 | 2017 | 382 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 323 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 543 | 0.030 |
Why?
|
| Molecular Weight | 4 | 1987 | 625 | 0.030 |
Why?
|
| Pyridones | 1 | 2016 | 348 | 0.030 |
Why?
|
| Thymectomy | 1 | 2013 | 79 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2013 | 46 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2014 | 32869 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 1394 | 0.030 |
Why?
|
| Quinazolines | 1 | 2018 | 923 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2013 | 6914 | 0.030 |
Why?
|
| Anilides | 1 | 2015 | 268 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 1997 | 669 | 0.030 |
Why?
|
| Peritonitis | 1 | 2013 | 89 | 0.030 |
Why?
|
| Piperidines | 1 | 2018 | 1036 | 0.030 |
Why?
|
| Benzimidazoles | 1 | 2016 | 428 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 2012 | 54 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 281 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 971 | 0.030 |
Why?
|
| Pancreas | 1 | 1996 | 714 | 0.030 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1994 | 315 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2016 | 551 | 0.030 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2018 | 923 | 0.030 |
Why?
|
| Alleles | 1 | 1998 | 2436 | 0.030 |
Why?
|
| Leukocytes | 1 | 1994 | 416 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 620 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 184 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 2501 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2017 | 2230 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 156 | 0.030 |
Why?
|
| Incidence | 2 | 2019 | 5672 | 0.030 |
Why?
|
| Rats, Inbred BUF | 3 | 1987 | 26 | 0.030 |
Why?
|
| Restriction Mapping | 3 | 1999 | 260 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 15863 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 735 | 0.030 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1991 | 41 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2014 | 492 | 0.030 |
Why?
|
| Consensus | 1 | 2015 | 978 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2013 | 231 | 0.020 |
Why?
|
| Chromaffin System | 1 | 2010 | 7 | 0.020 |
Why?
|
| Pneumococcal Infections | 1 | 2013 | 241 | 0.020 |
Why?
|
| Streptococcus pneumoniae | 1 | 2013 | 330 | 0.020 |
Why?
|
| Cell Division | 1 | 2015 | 2469 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 984 | 0.020 |
Why?
|
| Serine | 1 | 2012 | 388 | 0.020 |
Why?
|
| Spleen | 1 | 2013 | 669 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 487 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 423 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 304 | 0.020 |
Why?
|
| Survival | 1 | 2010 | 177 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 376 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2010 | 142 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2012 | 798 | 0.020 |
Why?
|
| Nucleic Acid Precursors | 1 | 1990 | 11 | 0.020 |
Why?
|
| Coronary Disease | 1 | 1994 | 764 | 0.020 |
Why?
|
| Colforsin | 1 | 1990 | 59 | 0.020 |
Why?
|
| Alanine | 1 | 2010 | 239 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1990 | 1206 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2015 | 795 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 6007 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 1209 | 0.020 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2009 | 36 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 575 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1990 | 225 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1992 | 573 | 0.020 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2009 | 69 | 0.020 |
Why?
|
| Abdomen | 1 | 2011 | 332 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2013 | 10053 | 0.020 |
Why?
|
| Adrenalectomy | 1 | 2010 | 188 | 0.020 |
Why?
|
| Risk | 1 | 2014 | 1969 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 521 | 0.020 |
Why?
|
| Insulin | 4 | 1997 | 1447 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2014 | 1867 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 700 | 0.020 |
Why?
|
| Piperazines | 1 | 2018 | 2100 | 0.020 |
Why?
|
| Growth Hormone | 1 | 1990 | 222 | 0.020 |
Why?
|
| Chromosome Deletion | 2 | 1990 | 1004 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2015 | 1334 | 0.020 |
Why?
|
| Viral Proteins | 2 | 2002 | 433 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2008 | 5600 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1997 | 830 | 0.020 |
Why?
|
| Genes, Suppressor | 1 | 2008 | 25 | 0.020 |
Why?
|
| Serum Albumin | 2 | 1987 | 252 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2013 | 1031 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2013 | 1092 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1492 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1987 | 4939 | 0.020 |
Why?
|
| Methyldimethylaminoazobenzene | 2 | 1985 | 2 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 1547 | 0.020 |
Why?
|
| Greece | 1 | 1988 | 22 | 0.020 |
Why?
|
| Dihydroxycholecalciferols | 1 | 1987 | 7 | 0.020 |
Why?
|
| 24,25-Dihydroxyvitamin D 3 | 1 | 1987 | 5 | 0.020 |
Why?
|
| Research Design | 1 | 2015 | 1545 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 6900 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 885 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 1742 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1985 | 410 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 2016 | 1349 | 0.020 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2011 | 690 | 0.020 |
Why?
|
| Biopsy | 1 | 2015 | 3450 | 0.020 |
Why?
|
| Tyrosine Transaminase | 1 | 1987 | 12 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 1080 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 1546 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 3433 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2014 | 2216 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2009 | 1050 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1986 | 156 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3818 | 0.020 |
Why?
|
| Radiography | 2 | 2002 | 1904 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1856 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 1244 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 3258 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 2447 | 0.020 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2009 | 588 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 745 | 0.020 |
Why?
|
| Culture Media | 1 | 1987 | 319 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2014 | 3890 | 0.020 |
Why?
|
| United States | 2 | 2019 | 15425 | 0.020 |
Why?
|
| Adenoviridae | 1 | 1991 | 1461 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1985 | 203 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 5675 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 2313 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 1985 | 223 | 0.020 |
Why?
|
| Endoscopy, Digestive System | 1 | 2006 | 202 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 1987 | 362 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2006 | 275 | 0.010 |
Why?
|
| Proline | 1 | 2004 | 130 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2016 | 3518 | 0.010 |
Why?
|
| Animals, Newborn | 2 | 1985 | 1330 | 0.010 |
Why?
|
| Inheritance Patterns | 1 | 2003 | 139 | 0.010 |
Why?
|
| Protein Kinases | 1 | 1987 | 874 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2013 | 2666 | 0.010 |
Why?
|
| Body Burden | 1 | 2003 | 65 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 4322 | 0.010 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2003 | 115 | 0.010 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2002 | 41 | 0.010 |
Why?
|
| Laboratories | 1 | 2003 | 145 | 0.010 |
Why?
|
| Certification | 1 | 2003 | 123 | 0.010 |
Why?
|
| Lung | 1 | 2013 | 3153 | 0.010 |
Why?
|
| Bone Resorption | 1 | 2002 | 138 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 2002 | 195 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 2001 | 33 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2002 | 164 | 0.010 |
Why?
|
| Carcinogens | 1 | 1983 | 382 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1987 | 1265 | 0.010 |
Why?
|
| Chile | 1 | 2001 | 61 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 2002 | 220 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2002 | 330 | 0.010 |
Why?
|
| Chromosome Mapping | 2 | 1995 | 1463 | 0.010 |
Why?
|
| Regeneration | 1 | 1984 | 278 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2001 | 81 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 694 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2001 | 111 | 0.010 |
Why?
|
| Oncogene Proteins | 1 | 2003 | 353 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 874 | 0.010 |
Why?
|
| Joints | 1 | 2001 | 47 | 0.010 |
Why?
|
| Arginine | 1 | 2004 | 500 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2002 | 271 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 1489 | 0.010 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 1999 | 14 | 0.010 |
Why?
|
| Reaction Time | 1 | 2001 | 232 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2008 | 2085 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 4963 | 0.010 |
Why?
|
| Hypocalcemia | 1 | 1999 | 59 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2003 | 585 | 0.010 |
Why?
|
| Actins | 1 | 2002 | 606 | 0.010 |
Why?
|
| Finland | 1 | 1999 | 55 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 6098 | 0.010 |
Why?
|
| Estrogens | 1 | 2002 | 749 | 0.010 |
Why?
|
| Family Health | 1 | 1999 | 325 | 0.010 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 1998 | 26 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 332 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2001 | 715 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1999 | 333 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1999 | 269 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2003 | 1014 | 0.010 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 1998 | 47 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2003 | 898 | 0.010 |
Why?
|
| Neck Dissection | 1 | 1999 | 290 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2003 | 1529 | 0.010 |
Why?
|
| Biological Availability | 1 | 1997 | 215 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2001 | 709 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1997 | 255 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2001 | 953 | 0.010 |
Why?
|
| Neurofibroma | 1 | 1996 | 31 | 0.010 |
Why?
|
| Hirschsprung Disease | 1 | 1996 | 46 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1999 | 572 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1990 | 1614 | 0.010 |
Why?
|
| Cysteine | 1 | 1996 | 214 | 0.010 |
Why?
|
| Aging | 1 | 1984 | 1535 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 4306 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 1095 | 0.010 |
Why?
|
| Saudi Arabia | 1 | 1995 | 39 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1994 | 48 | 0.010 |
Why?
|
| Lod Score | 1 | 1995 | 157 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1995 | 217 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1995 | 200 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 1999 | 8209 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2001 | 1612 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1995 | 507 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1999 | 2231 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1994 | 482 | 0.010 |
Why?
|
| Homozygote | 1 | 1995 | 716 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1995 | 970 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1997 | 1294 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1997 | 1374 | 0.010 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1990 | 43 | 0.010 |
Why?
|
| Cricetinae | 1 | 1990 | 701 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1990 | 293 | 0.010 |
Why?
|
| RNA | 2 | 1985 | 1010 | 0.010 |
Why?
|
| Species Specificity | 1 | 1990 | 774 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1989 | 190 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1997 | 4138 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1994 | 2593 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1990 | 931 | 0.000 |
Why?
|
| Deoxyribonuclease I | 1 | 1987 | 65 | 0.000 |
Why?
|
| Recurrence | 1 | 1994 | 4759 | 0.000 |
Why?
|
| Smoking | 1 | 1994 | 2440 | 0.000 |
Why?
|
| Cytosol | 1 | 1985 | 236 | 0.000 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1985 | 191 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1984 | 149 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1997 | 3858 | 0.000 |
Why?
|
| Albumins | 1 | 1984 | 249 | 0.000 |
Why?
|